SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-036933
Filing Date
2022-11-08
Accepted
2022-11-08 08:08:32
Documents
110
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnkd-10q_20220930.htm   iXBRL 10-Q 4144270
2 EX-10.1 mnkd-ex101_182.htm EX-10.1 145582
3 EX-31.1 mnkd-ex311_9.htm EX-31.1 17426
4 EX-31.2 mnkd-ex312_8.htm EX-31.2 17404
5 EX-32.1 mnkd-ex321_7.htm EX-32.1 7319
6 EX-32.2 mnkd-ex322_6.htm EX-32.2 7310
  Complete submission text file 0001564590-22-036933.txt   16596127

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20220930.xsd EX-101.SCH 113384
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20220930_cal.xml EX-101.CAL 89142
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20220930_def.xml EX-101.DEF 461338
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20220930_lab.xml EX-101.LAB 716795
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20220930_pre.xml EX-101.PRE 656917
104 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-10q_20220930_htm.xml XML 3462230
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 221367337
SIC: 2834 Pharmaceutical Preparations